NCT00304252View on ClinicalTrials.gov

Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

September 30, 2003

Conditions
Crohn's Disease
Interventions
DRUG

Interferon beta-1a

Trial Locations (5)

Unknown

Medical Information Office, Munich

Medical Information Office, Roma

Medical Information Office, Solna

Medical Information Office, Zug

Medical Information Office, Feltham

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00304252 - Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease | Biotech Hunter | Biotech Hunter